Big prostate cancer highlights from #ESMO23

Prostate Cancer Highlights from ESMO 2022Подробнее

Prostate Cancer Highlights from ESMO 2023Подробнее

ASCO GU 2023: highlights in prostate cancerПодробнее

#ESMO22 Highlights on ADT duration with post-operative radiotherapy in prostate cancer: RADICALS-HDПодробнее

The Truth About Life After Prostate RemovalПодробнее

ESOU Online: EAU22 highlights in prostate cancerПодробнее

Highlights in prostate cancer from ESMOПодробнее

#ESMO23 Genitourinary tumours (non-prostate) Track highlights with Chair Michiel van der HeijdenПодробнее

Prostate Cancer Insights ESMO Highlights for ChinaПодробнее

ESMO 2017: Prostate cancer highlightsПодробнее

Highlights on Lu-PSMA-617 in taxane-naive patients with mCRPC: The PSMAfore studyПодробнее

#ESMO21 Highlights on MFS analysis from comb. treatments in high-risk adv. prostate cancer: STAMPEDEПодробнее

GU Summary for ESMO 2023 | Dr. Rana McKay | Oncology Brothers #oncologyПодробнее

ASCO 2020 prostate cancer highlightsПодробнее

ESMO 2023 GU Cancer Highlights – SunRISE-1, EV-302, PSMAfore | Oncology BrothersПодробнее

Highlights in prostate cancer at ASCO GU 2023Подробнее

ESMO 2024 Prostate Cancer HighlightsПодробнее

#ESMO23 Gastrointestinal tumours (lower) Track highlights with Chair Chiara CremoliniПодробнее